VA Puget Sound Health Care
Welcome,         Profile    Billing    Logout  
 4 Trials 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kil, Jonathan
NCT02819856: SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity

Completed
2
40
US
Placebo, SPI-1000, SPI-1005 Ebselen 200mg Capsule x1, SPI-1005 Low Dose, SPI-1005 Ebselen 200mg Capsule x2, SPI-1005 Mid Dose, SPI-1005 Ebselen 200mg Capsule x3, SPI-1005 High Dose
Sound Pharmaceuticals, Incorporated, Medical University of South Carolina, Cystic Fibrosis Foundation
Ototoxicity
04/23
04/23
Quang, Tony S
No trials found

Download Options